Transaction #12477 · Form 4 · 0001162157-25-000005
Olema Pharmaceuticals, Inc. · Exercise / conversion · Common Stock
Olema Pharmaceuticals, Inc. · Transacted November 21, 2025 · Filed November 25, 2025
What does this filing report?
An SEC Form 4 filing for Olema Pharmaceuticals, Inc. records an exercise / conversion involving Common Stock on November 21, 2025. The reported quantity was 35,868. The filing date is November 25, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Olema Pharmaceuticals, Inc.
- Company CIK
- 0001750284
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 35,868
- Reported price
- 0.39
- Reference value
- 13,988.52
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 35,868
- Ownership description
- Not reported
- SEC acceptance time
- Nov 25, 2025, 6:00 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- RAPPAPORT ANDREW ↗
Director
CIK 0001162157
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The reporting person transferred 35,868 to the Rappaport Family Foundation, a charitable foundation of which the reporting person is an officer, as a bona fide gift for no consideration. The reporting person has voting and dispositive power over all securities owned by the foundation.
- F2
- The shares are held by the Rappaport Family Trust, of which the reporting person is co-trustee.
- F3
- The shares subject to the option are fully vested.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.